基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Sassine Andy, 董事. Director active across 2 companies, notably ICAD INC. In total, 13 disclosures have been published. Split: 2 buys · 7 sells. Total volume traded: €2m. Activity tracked since 13 September 2021. The latest transaction was disclosed on 15 August 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
SASSINE ANDY is Administrateur. He has filed 13 disclosures in total, and in the recent filings we hold, the transactions correspond to EUR 35,187 of purchases and EUR 1,920,549 of sales between 2016-01-06 and 2025-08-20. The companies mentioned are ICAD INC, where he is Director, and Arcturus Therapeutics Holdings Inc., where he is Chief Financial Officer.